A survey from The Ohio State University (OSU) has found that a majority of active armed services personnel and retired veterans, as well as their families, believe Veteran Administration (VA) doctors should be allowed to recommend psychedelics and medical marijuana to patients who stand to benefit from these treatments.
OSU researchers surveyed active-duty military personnel, veterans, their families, and even nonmilitary respondents from late August to early September 2023 on their thoughts about making medical marijuana and psychedelics accessible as treatment options. The 1,168 participants surveyed for the poll included 315 active as well as retired members of the military, 426 individuals from military families, plus 427 people outside the military.
Researchers say that due to the huge caseload of health problems in the veteran society plus the necessity of a variety of treatment alternatives for retired military service members, some scientists are exploring if and how veterans should access alternative treatments such as cannabis and psychedelics.
Medical marijuana has been around for more than two decades and is now legal in dozens of states across the United States. Several studies have found that the controversial plant has numerous potential health benefits and can help alleviate the symptoms of conditions that typically affect veterans, including anxiety disorders and chronic pain. However, VA doctors aren’t technically allowed to recommend medical marijuana to their patients because they are limited to prescribing medications that are approved by the U.S. Food and Drug Administration (FDA) for medical use.
Study authors also noted that studies on veteran issues rarely explore how veterans’ perspectives on specific drug issues in relation to the views held by individuals within their immediate plus broader communities.
The recent study drew its participants from the volunteer American Population Panel and asked those participants whether they were in agreement with a quartet of statements regarding cannabis and psychedelics. The last statement said that VA doctors should be able to recommend both marijuana and psychedelics if they believe their patients could benefit from them due to the “unique hardships and health conditions” veterans experience.
The majority of all the three groups surveyed said both drugs can be efficacious therapies. Even more stated that VA physicians should be permitted to recommend them to patients who may benefit. Additionally, all groups supported the idea that VA doctors shouldn’t need the FDA’s approval to recommend either psychedelics or cannabis.
The results of this survey underscores what the broader cannabis industry, including leading entities such as Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) have always believed, that marijuana could benefit in one way or the other nearly every section of the population that is struggling with health issues.
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
CannabisNewsWire is powered by IBN